secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cyclerion Therapeutics, Inc. (CYCN)
CIK:        0001755237
Form:       8-K
Filed at:   2021-10-28T23:59:59+00:00
Accession:  0001140361-21-035774
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Cyclerion appoints CEO Peter Hecht as interim CFO during CFO's maternity leave
------------------------------------------------------------------------------

- Peter M. Hecht, CEO, appointed Interim CFO effective October 27, 2021 while Anjeza Gjino is on maternity leave.
- Upon Ms. Gjino's return, she will resume her CFO role and Dr. Hecht will return to CEO duties.
- Other officers have assumed some of Ms. Gjino's responsibilities during her absence.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1755237/000114036121035774/0001140361-21-035774-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1755237/000114036121035774/brhc10030191_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-21-035774

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer